Maintaining consistent sleep schedules and avoiding heavy meals within 3 hours of bedtime helps manage this temporary issue
Expected and Temporary Symptoms These symptoms are common, especially during the first few weeks of treatment or after a dose increase
After years defined by shortages, high prices, and weekly injections, GLP-1 drugs like Wegovy and Zepbound are entering a new era
Modern pharmaceutical engineering has enabled the development of peptides with extended half-lives, shifting administration from multiple daily injections to weekly protocols
Safety advantage: Unlike HGH, AOD-9604 does not significantly impact IGF-1, insulin sensitivity, or blood sugar regulation Therapeutic potential: Initially investigated as an anti-obesity drug, it has since gained attention in the wellness and peptide therapy communities for weight loss and metabolic health